These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18834503)

  • 1. Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risks in genetic counselling.
    Ockhuysen-Vermey CF; Henneman L; van Asperen CJ; Oosterwijk JC; Menko FH; Timmermans DR
    BMC Cancer; 2008 Oct; 8():283. PubMed ID: 18834503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of a graphical presentation in addition to a frequency format in the context of familial breast cancer risk communication: a multicenter controlled trial.
    Henneman L; Oosterwijk JC; van Asperen CJ; Menko FH; Ockhuysen-Vermey CF; Kostense PJ; Claassen L; Timmermans DR
    BMC Med Inform Decis Mak; 2013 Apr; 13():55. PubMed ID: 23627498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Preferred Risk Formats Lead to Better Understanding? A Multicenter Controlled Trial on Communicating Familial Breast Cancer Risks Using Different Risk Formats.
    Henneman L; van Asperen CJ; Oosterwijk JC; Menko FH; Claassen L; Timmermans DR
    Patient Prefer Adherence; 2020; 14():333-342. PubMed ID: 32109999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making.
    Matloff ET; Moyer A; Shannon KM; Niendorf KB; Col NF
    J Womens Health (Larchmt); 2006 Sep; 15(7):843-56. PubMed ID: 16999640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presenting health risk information in different formats: the effect on participants' cognitive and emotional evaluation and decisions.
    Timmermans DR; Ockhuysen-Vermey CF; Henneman L
    Patient Educ Couns; 2008 Dec; 73(3):443-7. PubMed ID: 18722073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do women understand the odds? Risk perceptions and recall of risk information in women with a family history of breast cancer.
    Hopwood P; Howell A; Lalloo F; Evans G
    Community Genet; 2003; 6(4):214-23. PubMed ID: 15331867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
    Watson M; Lloyd S; Davidson J; Meyer L; Eeles R; Ebbs S; Murday V
    Br J Cancer; 1999 Feb; 79(5-6):868-74. PubMed ID: 10070883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
    Silverman TB; Vanegas A; Marte A; Mata J; Sin M; Ramirez JCR; Tsai WY; Crew KD; Kukafka R
    BMC Health Serv Res; 2018 Aug; 18(1):633. PubMed ID: 30103738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.
    Knerr S; Wernli KJ; Leppig K; Ehrlich K; Graham AL; Farrell D; Evans C; Luta G; Schwartz MD; O'Neill SC
    Contemp Clin Trials; 2017 May; 56():25-33. PubMed ID: 28257920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study.
    Yanes T; Meiser B; Young MA; Kaur R; Mitchell G; Barlow-Stewart K; Roscioli T; Halliday J; James P
    BMC Cancer; 2017 Jul; 17(1):491. PubMed ID: 28720130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalised risk communication for informed decision making about taking screening tests.
    Edwards AG; Evans R; Dundon J; Haigh S; Hood K; Elwyn GJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD001865. PubMed ID: 17054144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Communication in genetic counselling for breast/ovarian cancer.
    Dolbeault S; Flahault C; Stoppa-Lyonnet D; Brédart A
    Recent Results Cancer Res; 2006; 168():23-36. PubMed ID: 17073189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved health perception after genetic counselling for women at high risk of breast and/or ovarian cancer: construction of new questionnaires--an Italian exploratory study.
    Catania C; Feroce I; Barile M; Goldhirsch A; De Pas T; de Braud F; Boselli S; Adamoli L; Radice D; Rossi A; Spitaleri G; Noberasco C; Bonanni B
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):633-48. PubMed ID: 26577826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family history of breast cancer: what do women understand and recall about their genetic risk?
    Watson M; Duvivier V; Wade Walsh M; Ashley S; Davidson J; Papaikonomou M; Murday V; Sacks N; Eeles R
    J Med Genet; 1998 Sep; 35(9):731-8. PubMed ID: 9733031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.
    van den Heuvel LM; Hoedemaekers YM; Baas AF; van Tintelen JP; Smets EMA; Christiaans I
    BMJ Open; 2019 Jul; 9(7):e025660. PubMed ID: 31289060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalised risk communication for informed decision making about entering screening programs.
    Edwards A; Unigwe S; Elwyn G; Hood K
    Cochrane Database Syst Rev; 2003; (1):CD001865. PubMed ID: 12535419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailoring risk communication to improve comprehension: Do patient preferences help or hurt?
    Barnes AJ; Hanoch Y; Miron-Shatz T; Ozanne EM
    Health Psychol; 2016 Sep; 35(9):1007-16. PubMed ID: 27183307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A focus group study on breast cancer risk presentation: one format does not fit all.
    Dorval M; Bouchard K; Chiquette J; Glendon G; Maugard CM; Dubuisson W; Panchal S; Simard J
    Eur J Hum Genet; 2013 Jul; 21(7):719-24. PubMed ID: 23169493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.